Genocea Biosciences Inc (OTCPK:GGNNQ)
$ 0.0005 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Genocea Biosciences, Inc. - Shareholder/Analyst Call Transcript

May 12, 2020 / 04:00PM GMT
Operator

Good day, and welcome to the Genocea Virtual KOL Symposium on GEN-011 on Transforming T Cell Therapy for Solid Tumors. Today's conference is being recorded. I'll now turn the call over to Chip Clark, CEO of Genocea. Please go ahead, sir.

William D. Clark
Genocea Biosciences, Inc. - President, CEO & Director

Good morning, everyone. Thank you for joining us. Let me first express the hope that everybody in the audience is safe and well. Let me also express my gratitude for and pride with all of the Genoceans that we are here to represent today. When I think that it was just 18 months ago, or even less, that we decided to start a neoantigen cell therapy program and to be here today on the cusp of filing an IND with what we think is a potential best-in-class program is just really exciting.

So I will ask you, with that said, to heed this disclaimer because the Genoceans today will be making some forward-looking statements. After my brief introduction, I will turn things over to Dr. Eric Tran. Eric comes -- is a member of the Genocea SAB. He worked in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot